Lv21
198 积分 2023-09-26 加入
Over 132 Years Ago, the Inaugural Immunotherapy Treated Its First Head and Neck Cancer Patient
4小时前
待确认
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
16天前
已完结
Survival Outcomes in Stage III to IV Melanoma Before and After the Immunotherapy Era: Persistent Racial and Socioeconomic Disparities
20天前
已完结
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
1个月前
已完结
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
1个月前
已完结
Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort
1个月前
已完结
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype
2个月前
已完结
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype
2个月前
已完结
The immune modifying effects of chemotherapy and advances in chemo-immunotherapy
2个月前
已完结
The immune modifying effects of chemotherapy and advances in chemo-immunotherapy
2个月前
已完结
皖公网安备34019202002308
